Submission Details
| 510(k) Number | K214060 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 27, 2021 |
| Decision Date | September 19, 2022 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K214060 is an FDA 510(k) clearance for the LANDMARK REBOA Catheter, a Catheter, Intravascular Occluding, Temporary (Class II — Special Controls, product code MJN), submitted by Zien Medical Technologies, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on September 19, 2022, 266 days after receiving the submission on December 27, 2021. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4450.
| 510(k) Number | K214060 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 27, 2021 |
| Decision Date | September 19, 2022 |
| Days to Decision | 266 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | MJN — Catheter, Intravascular Occluding, Temporary |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.4450 |